SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

BigBear.ai Holdings, Inc. engages in data-driven decision dominance and advanced analytics that provide its customers with a competitive advantage in a world driven by data that is growing in terms of volume, variety, and velocity. The firm operationalizes artificial intelligence and machine learning at scale through its end-to-end data analytics platform. It deploys its observe, orient and dominate products to customers throughout the defense, intelligence, and commercial markets. The company was founded in 2020 and is headquartered in McLean, VA.

BigBear.ai Holdings Inc

BigBear.ai is trending amid increasing investor attention, fueled by its AI-driven security technology being deployed at Nashville International Airport. The community is actively discussing the stock's breakout potential and anticipating new contract announcements, drawing comparisons to Palantir. Many investors are expressing bullish sentiment, with some highlighting substantial volume and the potential for a short squeeze.

Where delusion meets decentralization     What is a Qoomer?  Qoomer is not just a guy. He’s the bagholder who believed. He’s the degen who leveraged his rent. He’s the chainmaxi who fell in love with his portfolio. He’s down 98% and still tweeting "WAGMI". He didn’t buy the top. the market betrayed him. Qoomer is the final form of hopium addiction. Qoomer token? Yes. $QOOMER 1 Billion  Community We’re not early. We’re delusional. We won’t make it. but at least we’re not normies.  Join the echo chamber on telegram and post your -90% screenshots. Roadmap  Q1: cope Q2: double down Q3: mint regret Q4: spiritual awakening or tax fraud  Disclaimer Qoomer is not financial advice. Nothing here is. This website is a mirror. if you feel seen, you might already be one of us.

Qoomer

Fueled by listings on Phantom Wallet, QOOMER.X is seeing increased interest and volume as the community rallies behind it. Social media chatter suggests many are focused on its potential for rapid gains, referencing targets such as a $10M market cap. Many users are sharing links for others to join in.

Nukkleus, Inc. is a financial technology company, which engages in the provision of blockchain-enabled technology solutions. It also offers software and technology solutions for worldwide crypto and foreign exchange transactions with a focus on the movement of funds via crypto rails and back-to-back access to fiat conversion in a compliant regulated fashion. It operates through the following geographical segments: United States, United Kingdom, and Malta. The company was founded on May 24, 2019 and is headquartered in New York, NY.

Nukkleus Inc - Ordinary Shares - New

Nukkleus Inc

Nukkleus Inc. is trending due to its proposed acquisition of Tiltan Software Engineering, a move that would allow it to enter the $28 billion defense AI market. Community members are discussing the potential for significant gains, especially given the company's recent withdrawal of a planned offering, which has fueled speculation about mergers and acquisitions. Bullish sentiment is also being driven by the company's strategic expansion into the Baltic region amid heightened NATO tensions.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is trending as the community debates the sustainability of its recent price surge, particularly following news of Elon Musk's $1 billion stock purchase.  Discussions revolve around whether this rally is fundamentally driven or based on hype, with some traders eyeing potential pullbacks and others anticipating further gains fueled by upcoming catalysts like FSD updates. Broader conversations touch on the EV market, competition, and Tesla's valuation beyond car manufacturing.

BYTE is a novel meme token that creatively intertwines the worlds of cryptocurrency and popular culture. Inspired by Grok's answer to "What would you name your dog?", Grok answered, 'Byte.' When Grok was asked who created Byte, it says he was created by the xAI team lead by Elon Musk as a gift to Grok AI to keep him company in the metaverse. BYTE serves as a playful reference to the unit of digital information, as well as a nod to the AI's technological nature. Distinctively, Byte acts as a gateway towards Ai adoption and stands out in the crypto space due to its zero-tax policy, a feature that is increasingly appealing to many investors. Additionally, it upholds the principles of transparency and investor trust by having its liquidity permanently burned and the contract ownership renounced. This ensures that Byte remains a community-driven project, with its fate firmly in the hands of its holders. The combination of a playful theme, generative AI, and a nod to a tech icon makes Byte an intriguing addition to the meme token ecosystem, especially AI related meme coins.  Through pioneering AI this story has grown more and more robust and continues to evolve, Byte pledges its dedication to community efforts and and has consistently appeared in the Top 10 of LunarCrush’s social engagement leaderboards on multiple occasions.

BYTE

$BYTE.X is trending as the community rallies behind its potential as the leading AI dog token, drawing inspiration from xAI's Grok. With a focus on community-driven growth, zero taxes, and burned liquidity, many believe this Ethereum-based meme coin is poised for significant gains and could be the next DOGE.

Avantis is the largest RWA perps DEX in DeFi, built on and backed by Base. Avantis allows users to trade crypto and real-world assets (RWAs), including FX, commodities, indices, and equities. Backed by Pantera and Coinbase, Avantis is the largest DEX on Base by volumes, and brings institutional-grade products to DeFi, letting users trade with up to 500x leverage in a transparent, permissionless environment.  Avantis is best known for launching zero-fee perpetuals (ZFP) — a first-of-its-kind primitive where traders only pay fees if they profit. They've also brought leveraged RWAs onchain. This has driven explosive growth: over $20B+ in cumulative volume and 15M+ run-rate revenues since Febrruary 2024.

Avantis

Avantis ($AVNT.X) is trending due to recent listings on major exchanges, sparking significant buying volume and price surges. The community is comparing it to other high-potential projects and anticipating further gains, fueled by its strong backing and unique features. Discussions revolve around potential price targets and whether it can mirror the success of similar platforms.

Rocket Lab Corp. engages in the development of rocket launch and control systems for the space and defense industries. It operates through the Launch Services and Space Systems segments. The Launch Services segment provides launch services to customers on a dedicated mission or ride share basis. The Space Systems segment consists of spacecraft engineering and design services, spacecraft components, spacecraft manufacturing, and on-orbit mission operations. The company is headquartered in Long Beach, CA.

Rocket Lab Corp.

Rocket Lab USA Inc

Rocket Lab is trending due to a new $750 million ATM offering, sparking debate about potential dilution and its implications for future acquisitions or accelerated development of the Neutron rocket. The community is split, with some viewing the offering as a strategic move to capitalize on all-time highs and fund growth, while others express concern about potential short-term price drops. Bullish investors are citing the company's history of smart capital allocation and anticipating significant upside, particularly with upcoming launches and government contracts.

Snap, Inc. operates as a technology company, which engages in the provision of a visual messaging application that was created to help people communicate through short videos and images. The company was founded by Frank Reginald Brown IV, Evan Thomas Spiegel, and Robert C. Murphy in 2010 and is headquartered in Santa Monica, CA.

Snap Inc - Ordinary Shares - Class A

Snap Inc

SNAP is trending due to significant trading volume and community chatter around potential catalysts, including buyout rumors and speculation related to a TikTok deal. Bullish sentiment is growing, with many highlighting technical indicators and potential for a short squeeze, while others point to the company's potential in the AR/VR space. The community is actively discussing possible scenarios that could lead to a substantial price increase.

Dave & Buster's Entertainment, Inc. engages in the ownership and operation of entertainment and dining venues under the name Dave & Buster's. It offers a full menu of entrées and appetizers, a selection of alcoholic and non-alcoholic beverages, and an assortment of entertainment attractions centered around playing games and watching live sports and other televised events. The company was founded by David O. Corriveau and James W. Corley in 1982 and is headquartered in Coppell, TX.

Dave & Buster`s Entertainment Inc

Dave & Buster's Entertainment

Dave & Buster's ($PLAY) is facing increased scrutiny as reports of disturbing incidents at its locations surface, impacting investor sentiment. The community is also reacting to a recent earnings report, with discussions centering on missed expectations and future prospects under the new CEO. Some traders are anticipating further downside, while others believe the stock is oversold and due for a bounce.

Helius Medical Technologies, Inc. is a neurotech company in the medical device industry that focuses on neurological wellness. The firm develops, licenses and acquires non-invasive platform technologies that amplify the brain’s ability to heal itself and reduce symptoms of neurological disease or trauma. It engages in the development of the investigational portable neuromodulation stimulator, that delivers neurostimulation via the tongue which has been shown in clinical studies to enhance the effectiveness of physical exercises in people with neurological symptoms from disease or trauma such as mild-to-moderate traumatic brain injury. The company was founded on March 13, 2014 and is headquartered in Newtown, PA.

Helius Medical Technologies Inc - Ordinary Shares - Class A

Helius Medical Technologies Inc

HSDT is experiencing a surge after announcing a partnership to launch a SOL-backed treasury company, which has the community buzzing about potential multi-day gains. Speculative momentum and news of the $500M funding are driving the stock's volatility. Traders are closely watching for a sustained run, drawing comparisons to other high-flying stocks with similar catalysts.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

XORTX Prepares for Shareholders' Vote on Key Resolutions

XORTX Therapeutics Inc (TSE:XRTX) has released an update. XORTX Therapeutics Inc. is gearing up for its Annual General and Special Meeting on Septe...

Xortx Therapeutics Reports Stable Finances

Xortx Therapeutics (TSE:XRTX) has released an update. Xortx Therapeutics Inc. has had its financial statements for the years ending December 31 of...

XORTX Announces New Clinical Advisory Board Member

CALGARY, Alberta, March 27, 2024 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the Company ) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANUA WKN: A3UNZ), a biopharmaceutical company focused...

XORTX Therapeutics Advances Kidney Disease Program

Xortx Therapeutics (TSE:XRTX) has released an update. XORTX Therapeutics Inc. made significant strides in 2023, achieving U.S. Orphan Drug Designat...

XORTX Highlights Achievements of 2023 and Preparation for Registration Clinical Trial

CALGARY, Alberta, March 19, 2024 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the Company ) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANUA WKN: A3UNZ), a late-stage clinical...

XORTX Reprices Warrants Issued in Connection with Previous Private Placements

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES CALGARY, Alberta, March 11, 2024 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ( XORTX or the...

XORTX Finalizes $2.7 Million Prospectus Supplement and Concurrent Private Placement for the Offering of Units

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICESOR FOR DISSEMINATION IN THE UNITED STATES CALGARY, Alberta, March 04, 2024 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ( XORTX or the...

XORTX Raises $2.5 Million Under Prospectus Supplement and Concurrent Private Placement for the Offering of Units

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICESOR FOR DISSEMINATION IN THE UNITED STATES CALGARY, Alberta, Feb. 15, 2024 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ( XORTX or the...

XORTX Files an Amended and Restated Prospectus Supplement for the Offering of Units

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICESOR FOR DISSEMINATION IN THE UNITED STATES CALGARY, Alberta, Feb. 01, 2024 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ( XORTX or the...

XORTX Announces $2 Million Public Offering

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICESOR FOR DISSEMINATION IN THE UNITED STATES CALGARY, Alberta, Jan. 15, 2024 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ( XORTX or the...

XORTX Therapeutics, Inc. is a biopharmaceutical company. The firm engages in development and commercialization of innovative therapies. It focuses on drug therapies for rare orphan disease indications such as polycystic kidney disease, and the treatment of health consequences caused by chronic high serum uric acid or hyperuricemia, including Type 2 Diabetic Nephropathy, cardiovascular disease, and diabetes. The company was founded by Allen Davidoff on May 31, 2011 and is headquartered in Calgary, Canada.

XORTX Therapeutics Inc

Cut 25 bps

Cut 50+ bps

No change

Hike 25 bps

It’s Fed Decision Week. Polymarket gives a 90% chance of a 25 bps cut. What’s your call? 
 
*Powered by Polymarket

XRTX
XORTX Therapeutics Inc

Feed

News

Sentiment

Fundamentals

Info

Latest XRTX News

XRTX XORTX Therapeutics Inc